Proteome Sciences Licenses Stroke Biomarkers to Undisclosed Dx Firm

genomeweb
360dx

Proteome Sciences Licenses Stroke Biomarkers to Undisclosed Dx Firm

Jun 29, 2006

NEW YORK, June 29 (GenomeWeb News) - Proteome Sciences licensed its stroke biomarkers to "one of the top 10 global leaders in clinical diagnostics," the company said yesterday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Enzo Biochem Fiscal Q1 Revenues Down 21 Percent
IdentiGen Receives €1.8M R&D Grant From Irish Government
SABCS 2018 Features Molecular Diagnostics Research
Metastatic ER+ Breast Cancers Acquire HER2 Mutations to Become Treatment Resistant
Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation
Agilent Granted Motion to Amend Complaint for Lawsuit Against Twist

The Scan

Not Mentioning It

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Lost Some Value There

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Slight Budget Trim

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

This Week in PLOS

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Main menu